---
title: "UNION SEMICONDUCTOR (HEFEI) released its 2024 annual performance, with a net profit attributable to shareholders of 160 million yuan, a year-on-year decrease of 18.48%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233447674.md"
description: "UNION SEMICONDUCTOR (HEFEI) released its 2024 annual performance, achieving revenue of 1.501 billion yuan during the reporting period, a year-on-year increase of 21.22%; net profit attributable to shareholders was 160 million yuan, a year-on-year decrease of 18.48%; net profit excluding non-recurring gains and losses was 134 million yuan, a year-on-year decrease of 20.33%; basic earnings per share were 0.19 yuan. The company plans to distribute a cash dividend of 0.95 yuan (tax included) for every 10 shares to all shareholders. The net cash flow from operating activities increased by 42.51% compared to the same period last year"
datetime: "2025-03-27T11:33:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233447674.md)
  - [en](https://longbridge.com/en/news/233447674.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233447674.md)
generator: "portal-rs"
---

# UNION SEMICONDUCTOR (HEFEI) released its 2024 annual performance, with a net profit attributable to shareholders of 160 million yuan, a year-on-year decrease of 18.48%

According to the Zhitong Finance APP, UNION SEMICONDUCTOR (HEFEI) (688403.SH) disclosed its 2024 annual report, stating that the company achieved revenue of 1.501 billion yuan during the reporting period, a year-on-year increase of 21.22%; net profit attributable to shareholders was 160 million yuan, a year-on-year decrease of 18.48%; net profit excluding non-recurring gains and losses was 134 million yuan, a year-on-year decrease of 20.33%; basic earnings per share were 0.19 yuan. The company plans to distribute a cash dividend of 0.95 yuan (tax included) for every 10 shares to all shareholders.

During the reporting period, the net cash flow generated from operating activities increased by 42.51% compared to the same period last year, mainly due to the implementation of the company's convertible bond fundraising projects, the gradual release of new production capacity, the continuous influx of customer orders, the increase in revenue scale, and the increase in cash received from sales of goods

### Related Stocks

- [688403.CN](https://longbridge.com/en/quote/688403.CN.md)

## Related News & Research

- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [Haitong International Expects Macau Industry GGR to Rise 6% YoY in Sep](https://longbridge.com/en/news/297725066.md)
- [Ripple Was Marked at $50 Billion in March. Secondary Trading Says $16 Billion](https://longbridge.com/en/news/297814138.md)
- [DynaResource Receives US$4.0 Million in IVA Tax Refund | DYNR Stock News](https://longbridge.com/en/news/298045265.md)
- [06:50 ETUnited Imaging secures CE mark for world's first dual wide-coverage CT family](https://longbridge.com/en/news/297901060.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**